- Home
- IMNM vs EEX Comparison
IMNM vs EEX Comparison
Compare IMNM & EEX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMNM
- EEX
- Stock Information
- Founded
- IMNM 2006
- EEX 2013
- Country
- IMNM United States
- EEX United States
- Employees
- IMNM N/A
- EEX N/A
- Industry
- IMNM Medicinal Chemicals and Botanical Products
- EEX Advertising
- Sector
- IMNM Health Care
- EEX Consumer Discretionary
- Exchange
- IMNM Nasdaq
- EEX Nasdaq
- Market Cap
- IMNM 945.8M
- EEX 910.8M
- IPO Year
- IMNM 2020
- EEX 2017
- Fundamental
- Price
- IMNM $10.30
- EEX $5.26
- Analyst Decision
- IMNM Strong Buy
- EEX Strong Buy
- Analyst Count
- IMNM 7
- EEX 2
- Target Price
- IMNM $24.57
- EEX $7.95
- AVG Volume (30 Days)
- IMNM 629.1K
- EEX 46.6K
- Earning Date
- IMNM 08-06-2025
- EEX 08-04-2025
- Dividend Yield
- IMNM N/A
- EEX 1.14%
- EPS Growth
- IMNM N/A
- EEX N/A
- EPS
- IMNM N/A
- EEX 0.04
- Revenue
- IMNM $12,589,000.00
- EEX $432,600,000.00
- Revenue This Year
- IMNM N/A
- EEX $15.99
- Revenue Next Year
- IMNM $154.73
- EEX $7.56
- P/E Ratio
- IMNM N/A
- EEX $143.60
- Revenue Growth
- IMNM 16.74
- EEX 9.96
- 52 Week Low
- IMNM $5.15
- EEX $3.22
- 52 Week High
- IMNM $16.73
- EEX $6.65
- Technical
- Relative Strength Index (RSI)
- IMNM 53.80
- EEX 61.22
- Support Level
- IMNM $9.37
- EEX $4.81
- Resistance Level
- IMNM $10.39
- EEX $5.04
- Average True Range (ATR)
- IMNM 0.49
- EEX 0.20
- MACD
- IMNM -0.06
- EEX 0.02
- Stochastic Oscillator
- IMNM 52.81
- EEX 90.41
About IMNM Immunome Inc.
Immunome Inc is a biopharmaceutical company. It is engaged in utilizing a proprietary human memory B cell platform to discover and develop first-in-class antibody therapeutics designed to change the way diseases are currently being treated. The objective of the company is to establish a broad pipeline of preclinical and clinical assets which it can efficiently develop through successive value inflection points. The company's primary focus areas are oncology and infectious diseases, including COVID-19. It operates in the U.S. Its current pipelines comprise IM-1021, a fibroblast activation protein (FAP), and others.
About EEX Emerald Holding Inc.
Emerald Holding Inc is a business-to-business (B2B) event organizer principally in the United States. The company is engaged in three complementary business lines; Connections division consists of a collection of B2B trade show franchises and other live events that provide exhibitors opportunities to engage with buyers and expand their brand's awareness in their industry; the Content division consists of B2B print publications and digital media products that complement existing trade show properties, and the Commerce division which offers software-as-a-service technology that enables year-round B2B buying and selling through Elastic Suite and Bulletin platforms for use by its customers. The Majority of the revenue for the company is generated from its Connections segment.